Inhibrx Biosciences, Inc. INBX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s total operating expenses?
- Inhibrx Biosciences, Inc. (INBX) reported total operating expenses of $30.93M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total operating expenses changed year-over-year?
- Inhibrx Biosciences, Inc.'s total operating expenses decreased by 27.9% year-over-year, from $42.9M to $30.93M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s total operating expenses has grown at a -21.5% compound annual growth rate (CAGR), from $221.02M to $136.33M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.